Simuni T

References (2)

Title : An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial - Shanbhag_2025_JAMA.Neurol__
Author(s) : Shanbhag NM , Padmanabhan JL , Zhang Z , Harel BT , Jia H , Kangarloo T , Yin W , Dowling AV , Laurenza A , Khudyakov P , Galinsky K , Latzman RD , Simuni T , Weintraub D , Horak FB , Lustig C , Maruff P , Simen AA
Ref : JAMA Neurol , : , 2025
Abstract :
PubMedSearch : Shanbhag_2025_JAMA.Neurol__
PubMedID: 39761063

Title : Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study - Ravina_2005_J.Neurol.Neurosurg.Psychiatry_76_934
Author(s) : Ravina B , Putt M , Siderowf A , Farrar JT , Gillespie M , Crawley A , Fernandez HH , Trieschmann MM , Reichwein S , Simuni T
Ref : Journal of Neurology Neurosurg Psychiatry , 76 :934 , 2005
Abstract :
PubMedSearch : Ravina_2005_J.Neurol.Neurosurg.Psychiatry_76_934
PubMedID: 15965198